Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Ovarian cancer metastatic to the brain: what is the optimal management?

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS.

J Surg Oncol. 2001 Nov;78(3):194-200; discussion 200-1. Review.

PMID:
11745806
2.

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S.

Gynecol Oncol. 2002 Jun;85(3):487-92.

PMID:
12051879
3.

Brain metastases in breast cancer: prognostic factors and management.

Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK.

Breast Cancer Res Treat. 2008 Oct;111(3):523-30. Epub 2007 Nov 8.

PMID:
17990100
4.

[Epithelial ovarian carcinoma metastatic to the brain: report on ten cases with review of literature].

Li ZT, Fu SL.

Zhonghua Fu Chan Ke Za Zhi. 2003 May;38(5):287-9. Chinese.

PMID:
12895313
5.
6.

[Treatment and prognostic factors for stage IV epithelial ovarian cancer].

Wu M, Shen K, Lang J.

Zhonghua Fu Chan Ke Za Zhi. 2000 Apr;35(4):200-3. Chinese.

PMID:
11776158
7.

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA.

Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28.

PMID:
19041126
8.

Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.

Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP.

Gynecol Oncol. 2008 Mar;108(3):505-9. doi: 10.1016/j.ygyno.2007.11.027. Epub 2008 Jan 11.

PMID:
18191184
9.

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.

Pectasides D, Aravantinos G, Fountzilas G, Kalofonos C, Efstathiou E, Karina M, Pavlidis N, Farmakis D, Economopoulos T, Dimopoulos MA.

Anticancer Res. 2005 Sep-Oct;25(5):3553-8. Review.

10.

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

Nicholson S, Gooden CS, Hird V, Maraveyas A, Mason P, Lambert HE, Meares CF, Epenetos AA.

Oncol Rep. 1998 Jan-Feb;5(1):223-6.

PMID:
9458326
11.

Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature.

Gadducci A, Tana R, Teti G, Fanucchi A, Pasqualetti F, Cionini L, Genazzani AR.

Anticancer Res. 2007 Nov-Dec;27(6C):4403-9.

12.

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.

Claude L, Perol D, Ray-Coquard I, Petit T, Blay JY, Carrie C, Bachelot T.

Radiother Oncol. 2005 Sep;76(3):334-9. Epub 2005 Jul 15.

PMID:
16024123
13.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
14.

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.

Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):519-26.

PMID:
12062592
15.

Colorectal cancer metastatic to the brain: time trends in presentation and outcome.

Nieder C, Pawinski A, Balteskard L.

Oncology. 2009;76(5):369-74. doi: 10.1159/000210026. Epub 2009 Mar 26.

PMID:
19321946
16.
17.

A comparison of survival rates for treatment of melanoma metastatic to the brain.

Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R.

Cancer Invest. 2004;22(4):492-7.

PMID:
15565805
19.

Brain metastases from bladder carcinoma: presentation, treatment and survival.

Mahmoud-Ahmed AS, Suh JH, Kupelian PA, Klein EA, Peereboom DM, Dreicer R, Barnett GH.

J Urol. 2002 Jun;167(6):2419-22.

PMID:
11992049
20.

Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review.

Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA.

Gynecol Oncol. 2007 Oct;107(1):79-85. Epub 2007 Jun 22. Review.

PMID:
17588647

Supplemental Content

Support Center